Not logged in.png)
Share.png)
SaveShared decision-making using a decision aid for patients with breast cancer considering breast reconstruction: study protocol for a cluster-randomised controlled trial in Japan
Sowa, Yoshihiro; Osaka, Wakako; Tsuge, Itaru; Komiya, Takako; Saiga, Miho; Taminato, Mifue; Nagura, Naomi; Shiraishi, Tomohiro; Seki, Hirohito; Otsuki, Yuki; Matsuoka, Yuki; Tomita, Shoichi; Akita, Shinsuke; Fujimoto, Hiroshi; Otani, Kazuhiro; Yoshimura, Kotaro Share Save Share Save Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cellsYamada, Hideyuki; Takada, Mamoru; Ghone, Dhaval; Yu, Muhan; Nagashima, Takeshi; Fujimoto, Hiroshi; Sakakibara, Junta; Hasegawa, Yoshie; Takao, Shintaro; Yamada, Akimitsu; Narui, Kazutaka; Ishikawa, Takashi; Suzuki, Aussie; Otsuka, Masayuki Share Save Eribulin Induces Chromosomal Instability and Enhances cGAS Expression in the Nucleus of TripleNegative Breast CancerYamada, Hideyuki; Takada, Mamoru; Suzuki, Aussie; Muhan, Yu; Nagashima, Takeshi; Fujimoto, Hiroshi; Sakakibara, Junta; Kasuya, Masaharu; Kawate, Takahiko; Miura, Daishu; Suzuki, Masato; Miyashita, Masaru; Narui, Kazutaka; Hasegawa, Yoshie; Ishikawa, Takashi; Otsuka, Masayuki Share Save Selective and Effective Targeting of TripleNegative Breast Cancer by CMPD1: Inhibition of MAP kinase-activated protein kinase 2 and Microtubule DynamicsTakada, Mamoru; Chen, Yu-Chia; Muhan, Yu; Yamada, Hideyuki; Sakakibara, Junta; Fujimoto, Hiroshi; Nagashima, Takeshi; Otsuka, Masayuki; Takaku, Motoki; Suzuki, Aussie Share Save Share Save Discovery of CMPD1 as a tumor-specific cytotoxic microtubule inhibitorTakada, M.; Chen, Y-C.; Wang, J.; Yamada, H.; Yu, M.; Sakakibara, J.; Fujimoto, H.; Nagashima, T.; Ohtsuka, M.; Takaku, M.; Suzuki, A. Share Save Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor modelsTeranaka, Ryotaro; Fujimoto, Hiroshi; Masuda, Takahito; Kuroda, Masayuki; Aoyagi, Yasuyuki; Nagashima, Takeshi; Takada, Mamoru; Sakakibara, Junta; Yamada, Hideyuki; Yamamoto, Hiroto; Kubota, Yoshitaka; Ohtsuka, Masayuki Share Save Scarless Donor Site for Breast Reconstruction by Endoscopically Assisted Extended Latissimus Dorsi Flap plus LipofillingAkita, Shinsuke; Tokumoto, Hideki; Yamaji, Yoshihisa; Kosaka, Kentaro; Arai, Minami; Ando, Nobuhiro; Maei, Haruka; Kubota, Yoshitaka; Fujimoto, Hiroshi; Mitsukawa, Nobuyuki Share Save The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patientsHayama, Shouko; Nakamura, Rikiya; Ishige, Takayuki; Sangai, Takafumi; Sakakibara, Masahiro; Fujimoto, Hiroshi; Ishigami, Emi; Masuda, Takahito; Nakagawa, Ayako; Teranaka, Ryotaro; Ota, Satoshi; Itoga, Sakae; Yamamoto, Naohito; Nagashima, Takeshi; Otsuka, Masayuki Share Save Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter studySurov, Alexey; Pech, Maciej; Meyer, Hans-Jonas; Bitencourt, Almir G., V; Fujimoto, Hiroshi; Baxter, Gabrielle C.; Santamaria, Gorane; Gilbert, Fiona J.; Wienke, Andreas Share Save Share Save A new method to optimize resection area using a radiation treatment planning system and deformable image registration for breast-conserving surgery after neoadjuvant chemotherapyMiyoshi, Tetsutaro; Yamaguchi, Satoshi; Fujimoto, Hiroshi; Yoshioka, Shigeru; Shiobara, Masayuki; Wakatsuki, Kazuo; Suda, Kosuke; Miyazawa, Kotaro; Aida, Toshiaki; Watanabe, Yoshihiro; Otsuka, Masayuki Share Save Share Save Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancerMasuda, Takahito; Fujimoto, Hiroshi; Teranaka, Ryotaro; Kuroda, Masayuki; Aoyagi, Yasuyuki; Nagashima, Takeshi; Sangai, Takafumi; Takada, Mamoru; Nakagawa, Ayako; Kubota, Yoshitaka; Yokote, Koutaro; Ohtsuka, Masayuki Share Save BRCA1 alterations with additional defects in DNA damage repair genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapyTakada, Mamoru; Kaneko, Yasuhiko; Haruta, Masayuki; Nagai, Shigenori; Inoue, Kenichi; Toduka, Katsunori; Kurozumi, Masafumi; Takei, Hiroyuki; Ogawa, Seishi; Nagashima, Takeshi; Sangai, Takafumi; Fujimoto, Hiroshi; Sakakibara, Junta; Teranaka, Ryotaro Share Save Share Save Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancerIwase, Toshiaki; Sangai, Takafumi; Fujimoto, Hiroshi; Sawabe, Yuji; Matsushita, Kazuyuki; Nagashima, Kengo; Sato, Yasunori; Nakagawa, Ayako; Masuda, Takahito; Nagashima, Takeshi; Ohtsuka, Masayuki Share Save Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edemaNakagawa, Ayako; Fujimoto, Hiroshi; Nagashima, Takeshi; Sangai, Takafumi; Takada, Mamoru; Masuda, Takahito; Teranaka, Ryotaro; Ota, Satoshi; Matsushima, Jun; Akita, Shinsuke; Ohtsuka, Masayuki Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
